FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,642 | +87.0% | 345 | +124.0% | 0.00% | – |
| Q1 2023 | $878 | -81.7% | 154 | -67.6% | 0.00% | – |
| Q4 2022 | $4,793 | -4.1% | 475 | +93.9% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 245 | +31.7% | 0.00% | – |
| Q2 2022 | $5,000 | +25.0% | 186 | +91.8% | 0.00% | – |
| Q1 2022 | $4,000 | -42.9% | 97 | -20.5% | 0.00% | – |
| Q4 2021 | $7,000 | +600.0% | 122 | +408.3% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 24 | +50.0% | 0.00% | – |
| Q2 2021 | $1,000 | -66.7% | 16 | -50.0% | 0.00% | – |
| Q1 2021 | $3,000 | +200.0% | 32 | +166.7% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 12 | -84.2% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 76 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -96.8% | 76 | -99.7% | 0.00% | -100.0% |
| Q4 2016 | $63,000 | – | 25,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |